Norethindrone

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

28 Suppliers, 15 USDMF, 7 CEP/COS, 3 JDMF, 5 EU WC, 7 NDC API, 13 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

174 Dossiers, 116 FDA Orange Book, 19 Europe, 13 Canada, 2 Australia, 16 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL-28 - 0.05MG;1MG, TABLET;ORAL-28 - 0.35MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.35MG, TABLET;ORAL-28 - 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 0.025MG;0.8MG

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 17 Roquette, 13 Microlex e.U, 12 BASF, 11 Sigachi Industries, 11 Corel Pharma Chem, 8 Gangwal Healthcare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Seppic, 7 Gangwal Chemicals, 6 Lonza Capsugel, 6 Boai NKY Pharmaceuticals Ltd, 6 DFE Pharma, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ideal Cures Pvt Ltd, 4 Kima Chemical, 4 SPI Pharma, 3 Ulanqab Kema New Material, 3 Pharmatrans-Sanaq, 3 Ingredion Pharma Solutions, 3 Prachin Chemical, 3 The Dow Chemical Company, 3 Vasa Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Qualicaps, 1 Shanghai Welltone Material Technology Co., Ltd, 1 DKSH, 1 Aeon Procare, 1 Huzhou Sunflower Pharmaceutical Co. Ltd, 1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 31 Direct Compression, 27 Controlled & Modified Release, 22 Disintegrants & Superdisintegrants, 22 Granulation, 16 Thickeners and Stabilizers, 15 Film Formers & Plasticizers, 15 Lubricants & Glidants, 14 Co-Processed Excipients, 11 Solubilizers, 10 Taste Masking, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Parenteral, 2 Coloring Agents, 2 Rheology Modifiers

GLOBAL SALES INFORMATION

137 US Medicaid Prescriptions, 28 Finished Drug Prices

MARKET PLACE

6 APIs, 1 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

1 EDQM Standards, 2 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 22 News

Manufacturers & Suppliers of Norethindrone Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Norethindrone

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

28 Suppliers

15 USDMF

7 CEP/COS

3 JDMF

5 EU WC

7 NDC API

13 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

174 Dossiers

116 FDA Orange Book

19 Europe

13 Canada

2 Australia

16 South Africa

8 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL-28 - 0.05MG;1MG

TABLET;ORAL-28 - 0.35MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.35MG

TABLET;ORAL-28 - 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, CHEWABLE;ORAL - 0.025MG;0.8MG

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

17 Roquette

13 Microlex e.U

12 BASF

11 Sigachi Industries

11 Corel Pharma Chem

8 Gangwal Healthcare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Seppic

7 Gangwal Chemicals

6 Lonza Capsugel

6 Boai NKY Pharmaceuticals Ltd

6 DFE Pharma

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Ideal Cures Pvt Ltd

4 Kima Chemical

4 SPI Pharma

3 Ulanqab Kema New Material

3 Pharmatrans-Sanaq

3 Ingredion Pharma Solutions

3 Prachin Chemical

3 The Dow Chemical Company

3 Vasa Pharmachem

1 Qianhao Chemical (Hebei) Co., Ltd

1 Nanjing Well Pharmaceutical

1 ACG Worldwide

1 Qualicaps

1 Shanghai Welltone Material Technology Co., Ltd

1 DKSH

1 Aeon Procare

1 Huzhou Sunflower Pharmaceutical Co. Ltd

1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders

44 Coating Systems & Additives

31 Direct Compression

27 Controlled & Modified Release

22 Disintegrants & Superdisintegrants

22 Granulation

TABLET;ORAL-28 - 0.35MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.035MG;0.4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons